• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性病毒性肝病患者血清III型前胶原肽、IV型胶原7S结构域、IV型胶原中央三螺旋结构及金属蛋白酶组织抑制剂:与肝脏组织学的关系

Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology.

作者信息

Murawaki Y, Ikuta Y, Koda M, Kawasaki H

机构信息

Second Department of Internal Medicine, Tottori University School of Medicine, Yonago, Japan.

出版信息

Hepatology. 1994 Oct;20(4 Pt 1):780-7. doi: 10.1002/hep.1840200403.

DOI:10.1002/hep.1840200403
PMID:7927217
Abstract

To assess the clinical value of serum biochemical markers, the aminoterminal peptide of type III procollagen, type IV collagen 7S domain, the central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases, as a marker of hepatic fibrosis, we measured these four serum markers in 132 patients with chronic viral liver disease and compared these serum markers with liver histological findings. Serum levels of these markers increased closely with the progress of liver disease, and the abnormal percentages of type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with cirrhosis were 97%, 95%, 83% and 48%, respectively. These four serum markers strongly correlated with the histological degree of periportal with or without bridging hepatocellular necrosis and of liver fibrosis and correlated weakly with the degree of intralobular degeneration and focal necrosis and the degree of portal inflammation. The correlation coefficients of serum type IV collagen 7S domain with periportal with or without bridging hepatocellular necrosis and with liver fibrosis were the highest among these four serum markers, suggesting that serum type IV collagen 7S domain is the most valuable diagnostic marker to assess the degree of liver fibrosis in chronic viral liver disease. When we assessed the ability of each serum marker to detect cirrhosis with a receiver operating curve, the best test was type IV collagen 7S domain, and the second best was type III procollagen peptide.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

为评估血清生化标志物,即III型前胶原氨基端肽、IV型胶原7S结构域、IV型胶原中央三螺旋结构和金属蛋白酶组织抑制剂作为肝纤维化标志物的临床价值,我们检测了132例慢性病毒性肝病患者的这四种血清标志物,并将这些血清标志物与肝脏组织学检查结果进行比较。这些标志物的血清水平随肝病进展而密切升高,肝硬化患者中III型前胶原肽、IV型胶原7S结构域、IV型胶原中央三螺旋结构和金属蛋白酶组织抑制剂的异常百分比分别为97%、95%、83%和48%。这四种血清标志物与伴有或不伴有桥接性肝细胞坏死的汇管区组织学程度及肝纤维化程度密切相关,与小叶内变性和局灶性坏死程度及门脉炎症程度相关性较弱。在这四种血清标志物中,血清IV型胶原7S结构域与伴有或不伴有桥接性肝细胞坏死的汇管区及肝纤维化的相关性系数最高,提示血清IV型胶原7S结构域是评估慢性病毒性肝病肝纤维化程度最有价值的诊断标志物。当我们用受试者工作特征曲线评估每种血清标志物检测肝硬化的能力时,最佳检测指标是IV型胶原7S结构域,其次是III型前胶原肽。(摘要截短至250字)

相似文献

1
Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology.慢性病毒性肝病患者血清III型前胶原肽、IV型胶原7S结构域、IV型胶原中央三螺旋结构及金属蛋白酶组织抑制剂:与肝脏组织学的关系
Hepatology. 1994 Oct;20(4 Pt 1):780-7. doi: 10.1002/hep.1840200403.
2
Serum markers for hepatic fibrosis in alcoholic liver disease: which is the best marker, type III procollagen, type IV collagen, laminin, tissue inhibitor of metalloproteinase, or prolyl hydroxylase?酒精性肝病中肝纤维化的血清标志物:哪种是最佳标志物,III型前胶原、IV型胶原、层粘连蛋白、金属蛋白酶组织抑制剂还是脯氨酰羟化酶?
Alcohol Clin Exp Res. 1996 Dec;20(9):1512-7. doi: 10.1111/j.1530-0277.1996.tb01692.x.
3
Comparison of serum 7S fragment of type IV collagen and serum central triple-helix of type IV collagen for assessment of liver fibrosis in patients with chronic viral liver disease.比较血清IV型胶原7S片段和血清IV型胶原中央三螺旋结构用于评估慢性病毒性肝病患者肝纤维化的情况。
J Hepatol. 1996 Feb;24(2):148-54. doi: 10.1016/s0168-8278(96)80023-7.
4
Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases.血清I型前胶原羧基末端前肽与III型前胶原氨基末端前肽的比值,对于慢性病毒性肝病中的进行性纤维化形成来说,是比每种单一前肽及IV型胶原7S结构域更好的指标。
Dig Dis Sci. 1995 Jan;40(1):21-7. doi: 10.1007/BF02063936.
5
Serum aminoterminal type III procollagen peptide and the 7S domain of type IV collagen in patients with alcohol abuse. Relation to ultrastructural fibrosis in the acinar zone 3 and to serum hyaluronan.酒精滥用患者血清Ⅲ型前胶原氨基端肽及Ⅳ型胶原7S结构域与腺泡3区超微结构纤维化及血清透明质酸的关系
Liver. 1987 Dec;7(6):339-46. doi: 10.1111/j.1600-0676.1987.tb00365.x.
6
Significance of serum tissue inhibitor of metalloproteinases-1 in various liver diseases.血清金属蛋白酶组织抑制因子-1在各种肝脏疾病中的意义
J Hepatol. 1996 Feb;24(2):177-84. doi: 10.1016/s0168-8278(96)80027-4.
7
Noninvasive determination of liver collagen content in chronic hepatitis. Multivariate regression modeling with blood chemical parameters as variables.慢性肝炎中肝脏胶原含量的无创测定。以血液化学参数为变量的多变量回归建模。
J Gastroenterol. 1997 Jun;32(3):355-60. doi: 10.1007/BF02934493.
8
Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. Relationship to liver histology and conventional liver tests.慢性肝炎患者血清I型胶原蛋白和III型前胶原N端肽。与肝脏组织学及传统肝功能检查的关系。
J Hepatol. 1991 Mar;12(2):139-44. doi: 10.1016/0168-8278(91)90929-6.
9
Serum type III procollagen and basement membrane proteins as noninvasive markers of hepatic pathology in Indian childhood cirrhosis.血清III型前胶原和基底膜蛋白作为印度儿童肝硬化肝脏病理的非侵入性标志物。
Hepatology. 1987 Nov-Dec;7(6):1249-53. doi: 10.1002/hep.1840070612.
10
Clinical significance of serum 7S collagen in various liver diseases.血清7S胶原蛋白在各种肝脏疾病中的临床意义
Clin Biochem. 1992 Dec;25(6):467-70. doi: 10.1016/0009-9120(92)90150-q.

引用本文的文献

1
Accuracy of type IV collagen 7S versus Enhanced Liver Fibrosis score for diagnosing fibrosis in patients with metabolic dysfunction-associated steatotic liver disease.IV型胶原7S与增强肝纤维化评分在诊断代谢功能障碍相关脂肪性肝病患者肝纤维化中的准确性
Hepatol Commun. 2024 Dec 11;9(1). doi: 10.1097/HC9.0000000000000563. eCollection 2025 Jan 1.
2
Significance of Prediction Models for Post-Hepatectomy Liver Failure Based on Type IV Collagen 7s Domain in Patients with Hepatocellular Carcinoma.基于IV型胶原7s结构域的预测模型对肝细胞癌患者肝切除术后肝衰竭的意义
Cancers (Basel). 2024 May 20;16(10):1938. doi: 10.3390/cancers16101938.
3
Metabolic-Dysfunction-Associated Steatotic Liver Disease-Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments.
代谢功能障碍相关性脂肪性肝病及其病理生理学、与动脉粥样硬化和心血管疾病的关联,以及治疗方法。
Int J Mol Sci. 2023 Oct 23;24(20):15473. doi: 10.3390/ijms242015473.
4
Recent Advances in the Pathogenesis and Clinical Evaluation of Portal Hypertension in Chronic Liver Disease.慢性肝病门静脉高压症发病机制及临床评估的新进展。
Gut Liver. 2024 Jan 15;18(1):27-39. doi: 10.5009/gnl230072. Epub 2023 Oct 16.
5
Non-Invasive Measurement of Hepatic Fibrosis by Transient Elastography: A Narrative Review.瞬时弹性成像技术无创评估肝纤维化:一项叙述性综述。
Viruses. 2023 Aug 13;15(8):1730. doi: 10.3390/v15081730.
6
A novel noninvasive formula for predicting cirrhosis in patients with chronic hepatitis C.一种用于预测慢性丙型肝炎患者肝硬化的新型无创公式。
PLoS One. 2021 Sep 10;16(9):e0257166. doi: 10.1371/journal.pone.0257166. eCollection 2021.
7
Molecular Crosstalk between the Hepatitis C Virus and the Extracellular Matrix in Liver Fibrogenesis and Early Carcinogenesis.丙型肝炎病毒与细胞外基质在肝纤维化和早期癌变过程中的分子串扰
Cancers (Basel). 2021 May 9;13(9):2270. doi: 10.3390/cancers13092270.
8
Utility of collagen-derived peptides as markers of organ injury in patients with acute heart failure.胶原蛋白衍生肽作为急性心力衰竭患者器官损伤标志物的效用。
Open Heart. 2020 Apr 5;7(1):e001041. doi: 10.1136/openhrt-2019-001041. eCollection 2020.
9
Pre-hepatectomy type IV collagen 7S predicts post-hepatectomy liver failure and recovery.术前 IV 型胶原 7S 预测肝切除术后肝衰竭和恢复情况。
World J Gastroenterol. 2020 Feb 21;26(7):725-739. doi: 10.3748/wjg.v26.i7.725.
10
Usefulness of serum Mac-2 binding protein glycosylation isomer in patients undergoing hepatectomy: A case controlled study.血清Mac-2结合蛋白糖基化异构体在肝切除患者中的应用价值:一项病例对照研究。
Ann Med Surg (Lond). 2019 Oct 17;48:17-22. doi: 10.1016/j.amsu.2019.10.014. eCollection 2019 Dec.